Healthcare Professionals

Committed to helping you meet the evolving challenges and opportunities in patient care.

Healthcare Professionals
  • Primary Care

    Supporting every aspect of your clinical practice, including physical exam, diagnostic cardiology, vitals monitoring and vision screening

  • Hospital Care

    Advancing products and technologies designed to speed patient recovery and streamline clinical workflows

  • Surgical Care

    Delivering innovations that enable reduced operating times, faster patient recovery and improved outcomes

  • Kidney Care

    Pioneering care in hemodialysis (HD), peritoneal dialysis (PD) and digital health to support better outcomes for your patients

  • Nutritional Care

    Personalizing nutritional care designed to improve patients’ health in the hospital, the ICU and at home

  • Respiratory Care

    Helping your patients with respiratory therapies designed to simplify delivery and improve mobility

  • Our Products

    Our portfolio of acute, nutritional, renal, hospital and surgical care products helps advance healthcare around the world.

Perspectives

For nearly a century, we have worked at the intersection of saving and sustaining lives.

Perspectives

Our Story

Our 90-year heritage gives us distinct perspective on the needs of patients and caregivers. We lead today by putting those insights to work to deliver new, better healthcare solutions and access to care in the communities where we live and work.

Our Story
  • Our Leadership

    Our forward-looking leadership team is a driving force in ensuring we meet the needs of all our stakeholders – every day and everywhere.

  • Our Governance

    We are proud of our strong commitment to maintaining the highest standards of corporate governance.

  • Fueling Collaborative Innovation

    Nurturing a culture of innovation is critical to delivering on our mission to save and sustain lives. We partner with the healthcare community to continually find more efficient, smarter ways to help solve the world's most pressing healthcare challenges.

  • Corporate Responsibility

    We strive to create lasting value by empowering our patients, protecting our planet and championing our people and communities.

  • Diversity, Equity & Inclusion

    We are committed to attracting, motivating and retaining an inclusive and diverse workforce.

  • Our History

    For nearly a century, we’ve been focused on saving and sustaining lives and elevating patient care.

Patients

Helping you reach a healthy life, full of possibility.

Patients
  • General Healthcare

    Whether you are receiving care in the hospital, at your doctor’s office or at home, we are here to support every step of your journey.

  • Nutritional Care

    When medical conditions prevent you from adequately feeding yourself, we provide life-saving clinical nutrition options to help you regain your nutritional status.

  • Kidney Care

    Kidney disease is an ongoing journey for you and your family. While every journey is unique, Baxter is committed to supporting access to care options to meet your medical and lifestyle needs.

  • Respiratory Care

    We are committed to helping you with innovative products that deliver effective, proven respiratory therapy in the hospital and at home.

Search Results

Renal Care Content

Baxter, NAACP and the Alliance For Home Dialysis Expand Program to Increase Awareness of Kidney Care Among African Americans

Baxter International Inc. (NYSE:BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access, Choice, and Equity (ACE) program will be expanded for a third year.

2019 First Quarter Financial Results Thumbnail

Baxter Reports First-Quarter 2019 Results

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the first quarter of 2019 and increased its full-year 2019 earnings outlook.

Financial Content

Baxter to Present at the Bank of America Merrill Lynch Health Care Conference 2019

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the 2019 Bank of America Merrill Lynch Health Care Conference in Las Vegas on May 15, 2019.  Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 8:40 a.m. Pacific Time. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through November 11, 2019.

Baxter Unveils the Latest Evolution of Floseal at AORN Meeting

Baxter International Inc. (NYSE:BAX), a global leader in advancing surgical innovation, today announced that it has received U.S. Food and Drug Administration (FDA) approval for faster preparation of its leading hemostatic product, Floseal Hemostatic Matrix, at the 2019 Association of periOperative Registered Nurses (AORN) Global Surgical Conference and Expo.

Baxter to Host Webcast of Annual Meeting of Stockholders

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a webcast of its Annual Meeting of Stockholders on Tuesday, May 7, 2019 at 9 a.m. Central Daylight Time.

Baxter Highlights Advancements in Clinical Nutrition at ASPEN Conference

Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, today announced it will launch Clinolipid (20% Lipid Injectable Emulsion), its proprietary olive oil-based lipid emulsion, in the U.S. later this year — marking the growth of Baxter's lipid portfolio.

Alaska PD Thumbnail

Confidence in the Wake of Natural Disaster

Through remote patient technology, nurses were able to stay connected with peritoneal dialysis patients after an earthquake.

Critical Care Content

Baxter and bioMérieux Announce Collaboration to Improve Identification and Treatment of Acute Kidney Injury

Baxter International Inc. (NYSE: BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the goal to rapidly identify and inform treatment of acute kidney injury (AKI). The announcement was made at the International Symposium on Intensive Care and Emergency Medicine (ISICEM) this week.

Financial Content

Baxter to Host First Quarter 2019 Financial Results Conference Call for Investors

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its first quarter 2019 financial results on Thursday, April 25, 2019, at 7:30 a.m. Central Time. To access the call, dial (844) 886-1929 (domestic) or (225) 239-4663 (international).  Please dial into the call at least 10 minutes prior to the start for the operator to connect you. The Conference ID is 6993043.

Epti Thumbnail

Baxter Announces U.S. FDA Approval and Launch of Ready-To-Use Cardiovascular Medicine Eptifibatide

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. Food and Drug Administration (FDA) approval and launch of ready-to-use eptifibatide. Baxter’s presentation of eptifibatide is the first of its kind available in a flexible container.